Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP735354.RAlxBxymkh8a5MqUFWPMlVJ8l9Otz4Dweqi8R-wdAFMZs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP735354.RAlxBxymkh8a5MqUFWPMlVJ8l9Otz4Dweqi8R-wdAFMZs130_assertion type Assertion NP735354.RAlxBxymkh8a5MqUFWPMlVJ8l9Otz4Dweqi8R-wdAFMZs130_head.
- NP735354.RAlxBxymkh8a5MqUFWPMlVJ8l9Otz4Dweqi8R-wdAFMZs130_assertion description "[To investigate catecholamine phenotypes and the effects of a tyrosine hydroxylase inhibitor in individuals with the 22q11.2 deletion syndrome and low-activity catechol-O-methyltransferase (COMT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP735354.RAlxBxymkh8a5MqUFWPMlVJ8l9Otz4Dweqi8R-wdAFMZs130_provenance.
- NP735354.RAlxBxymkh8a5MqUFWPMlVJ8l9Otz4Dweqi8R-wdAFMZs130_assertion evidence source_evidence_literature NP735354.RAlxBxymkh8a5MqUFWPMlVJ8l9Otz4Dweqi8R-wdAFMZs130_provenance.
- NP735354.RAlxBxymkh8a5MqUFWPMlVJ8l9Otz4Dweqi8R-wdAFMZs130_assertion SIO_000772 11502905 NP735354.RAlxBxymkh8a5MqUFWPMlVJ8l9Otz4Dweqi8R-wdAFMZs130_provenance.
- NP735354.RAlxBxymkh8a5MqUFWPMlVJ8l9Otz4Dweqi8R-wdAFMZs130_assertion wasDerivedFrom befree-20150227 NP735354.RAlxBxymkh8a5MqUFWPMlVJ8l9Otz4Dweqi8R-wdAFMZs130_provenance.
- NP735354.RAlxBxymkh8a5MqUFWPMlVJ8l9Otz4Dweqi8R-wdAFMZs130_assertion wasGeneratedBy ECO_0000203 NP735354.RAlxBxymkh8a5MqUFWPMlVJ8l9Otz4Dweqi8R-wdAFMZs130_provenance.